Vice President, CMC Drug Substance Development at Mersana Therapeutics
Tom Wagler is a(n) Vice President, CMC Drug Substance Development working at Mersana Therapeutics.
Get Tom Wagler's email for freeName | Position | Contacts | ||
---|---|---|---|---|
JS | Jennie Shrm-Cp | Associate Director Human Resources & FacilitiesMersana Therapeutics | @mersana.com(617) | Get contact |
RB | Reddy Bollu | Principal ScientistMersana Therapeutics | @mersana.com(617) | Get contact |
MP | Marina Protopopova | Principal ScientistMersana Therapeutics | @mersana.com(617) | Get contact |
TL | Timothy Lowinger | Chief Science & Technology OfficerMersana Therapeutics | @mersana.com(617) | Get contact |
NM | Naniye Malli | Associate Director, Immuno-Oncology, Antibody-Drug ConjugatesMersana Therapeutics | @mersana.com(617) | Get contact |
AM | Ashley Milton | VP, Clinical PharmacologyMersana Therapeutics | @mersana.com(617) | Get contact |
LD | Lauren Doherty | Senior Clinical Trial ManagerMersana Therapeutics | @mersana.com(617) | Get contact |
JB | June Buchanan | Director Clinical OperationsMersana Therapeutics | @mersana.com(617) | Get contact |
LK | Leigh Keating | Clinical Trial ManagerMersana Therapeutics | @mersana.com(617) | Get contact |
AP | Anna Protopapas | President and CEOMersana Therapeutics | @mersana.com(617) | Get contact |